Today, non-communicable diseases (NCD) are the cause of the majority of diseases and mortality worldwide. Meanwhile, cancer is the main cause of mortality and the most important obstacle to increasing life expectancy in all countries (
1). It is a serious threat to health and the second cause of mortality around the world (
2). Based on the estimations of the World Health Organization (WHO), in 2015, cancer was the first or second main cause of mortality before the age of 70 years in 91 countries out of the 172 countries of the world.
The incidence of cancer and the resulting mortality is rapidly increasing globally (
1). In its 2020 report, the WHO noted that in 2018, 18.1 million people worldwide had cancer, and 9.6 million people lost their lives due to this disease. By 2040, these values will be almost doubled. Cancer is the cause of about 30% of all the cases of mortality due to NCD in adults aged 30 to 69 years (
3). Based on the study by Kazem Zendehdel in Iran, about 110,000 cases of cancer occurred in 2018, of whom about 56,000 died (
4).
The heavy costs of medical interventions and services for cancer treatment and the costs of hospitalization, outpatient visits, and medications are the consequences of cancer. Moreover, indirect costs such as the loss of productivity due to the disease and early mortality can be regarded as complications of cancer. To these, psychological and social problems resulting from cancer, including the pain and suffering caused by the disease and its treatment, can be added (
5).
Mutuma noted that cancer diagnosis has wide-ranging economic and social consequences for the person, family, and society (
6).
Controlling cancer aiming to reduce its prevalence, complications, , and mortality, carrying out systematic evidence-based interventions to prevent, early diagnosis and treatments and alleviatory care may lead to quality-of-life improvement among patients (
7,
8).
Effective planning for cancer control requires accurate data, including reliable registries for cancer, monitoring, and evaluation programs for quality assurance (
9).
According to Bray et al., the quality of data and evaluation of the data in cancer registries should have features of comparability, validity, timeliness, and completeness (
10). Furthermore, the WHO published a report in 2016 on cancer prevention and control and emphasized that effective policies for this purpose should be designed based on accurate data (
9). Cancer registry data help describe the burden and etiology of cancer, evaluate primary and secondary prevention effects, and perform health service planning (
11).
The achievement of these objectives needs the use of information classification and coding standards. International Statistical Classification of Diseases and Related Health Problems,10th Revision (ICD-10) is among the most vital epidemiological tools for monitoring the incidence and prevalence of specific diseases and other health-related problems (
12).
The retrieval of information from databases enhances policy-makers’ understanding of the incidence and prevalence of diseases and enables them to implement measures to reduce and track diseases and allocate resources. This will not be realized unless the information is accurately coded and classified (
13).
High-quality data are specific, accurate, and comprehensive diagnostic codes that are important both in research and in decision-making (
14).
The use of coding instructions improves the accuracy and quality of cancer registry data (
15). Wilson et al. stated that an understanding of the completeness of codes and the quality of clinical coding is essential to survival analysis in cancer registries (
16). Coding errors prevent the productivity and effective performance and management of hospitals and can potentially lead to inaccurate national statistics about the incidence rate of the disease (
17). The quality of coded data depends on two factors: first, to what extent the healthcare providers document the diagnoses and procedures accurately and completely, and second, how accurately and consistently the documents are coded by clinical coders (
18). Therefore, attention to high-quality coding is of utmost importance. Still, there are numerous obstacles to high-quality coding: (1) coders limited in their abilities for adding, modifying, or interpreting medical documents, (2) incompleteness of documents, (3) inconsistencies in medical records, (4) the use of different terms for describing clinical diagnoses, and (5) a communication gap between coders and doctors (
14). WHO emphasizes that clinical coders need knowledge of medical terminology, legal aspects, health information, and health data standards, and training is an inseparable component of health information (
12).
Professional coding training is an essential way for reducing code inconsistencies (
19).
Concerning the role of coders in assigning an accurate code, and since the lack of attention to the quality of coding and coding errors leads to the inaccurate classification of diseases, trusting data with unspecified or poor classification quality will have risks for both healthcare providers and managers in planning and epidemiological and medical research (
13). This highlights the significance of continuous training and ensuring the effectiveness of this training on accurate cancer classification and coding and, therefore, the achievement of high-quality data in cancer registries.
Coder training provides general and specialized knowledge and skills for using clinical coding standards at a national level (
20).